Thursday, July 3, 2008

Janssen Announces Launch of Authorized Generic for Risperdal

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced that it has launched an authorized generic version of RISPERDAL(R) (risperidone) through Patriot Pharmaceuticals, L.L.C. Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of companies.

The details can be read here.

No comments: